Search - tctmd.com

Displaying 801 - 820 of 874

Sort: Relevancy | Date

News Daily News

Drug-Eluting Balloons Show ‘Impressive’ Results in Below-the-Knee Lesions

Jason Kahn

September 08, 2011

News Industry News

Abbott Initiates International ABSORB BTK Clinical Trial for Treatment of Below-the-Knee Critical Limb Ischemia

September 08, 2011

News Conference News

CRISP AMI: Balloon Pump Therapy Fails to Help STEMI Patients Without Shock

Jason Kahn

September 06, 2011

News Conference News

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

September 02, 2011

News Conference News

Study Investigates Which Elderly Patients Benefit from Aggressive Treatment

September 01, 2011

News Conference News

Halting Clopidogrel in First Year Following Acute MI Hazardous

September 01, 2011

News Industry News

St. Jude Medical Begins U.S. Trial Studying ST Segment Monitoring Technology

August 31, 2011

News Conference News

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

August 31, 2011

News Daily News

Adaptive Responses to Radiation Exposure in Cath Labs May Protect Physicians

L.A. McKeown

August 26, 2011

News Daily News

Postconditioning Again Fails to Reduce Reperfusion Injury After STEMI

August 24, 2011

News Daily News

CT Perfusion Imaging Captures Anatomy, Function

Caitlin E. Cox

August 24, 2011

News Daily News

No Apparent Advantage for Everolimus vs. Paclitaxel Stents in Diabetic Patients

L.A. McKeown

August 19, 2011

News Daily News

Carbon Dioxide Angiography May Be Alternative to Iodinated Contrast in High-Risk Patients

L.A. McKeown

August 16, 2011

News Daily News

SES Fractures Raise Revascularization Risk, But Not Beyond 1 Year

Caitlin E. Cox

August 05, 2011

News Daily News

ESSENCE-DIABETES Published: Xience, Cypher Equally Equipped to Treat Diabetics

Caitlin E. Cox

August 03, 2011

News Daily News

Studies Support Staged PCI for STEMI Patients with Multivessel Disease

August 01, 2011

News Industry News

NIH Awards $84 Million Grant to NYU Langone Medical Center and Partnering Institutions for First-of-Its-Kind Comparative Effectiveness ISCHEMIA Clinical Trial

August 01, 2011

News Daily News

Stenting Suitable for Extracranial Vertebral Disease

Caitlin E. Cox

July 27, 2011

News Industry News

OrbusNeich's GenousTM Stent Enables Early and Safe Discontinuation of Dual Antiplatelet Therapy in High-Risk Patients Requiring Nondeferrable, Non-Cardiac Surgery

July 18, 2011

News Industry News

St. Jude Medical Announces European Approval of First and Only Combined FFR and OCT System

July 14, 2011

Advertisement

Drug-Eluting Balloons Show ‘Impressive’ Results in Below-the-Knee Lesions

Abbott Initiates International ABSORB BTK Clinical Trial for Treatment of Below-the-Knee Critical Limb Ischemia

CRISP AMI: Balloon Pump Therapy Fails to Help STEMI Patients Without Shock

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

Study Investigates Which Elderly Patients Benefit from Aggressive Treatment

Halting Clopidogrel in First Year Following Acute MI Hazardous

St. Jude Medical Begins U.S. Trial Studying ST Segment Monitoring Technology

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

Adaptive Responses to Radiation Exposure in Cath Labs May Protect Physicians

Postconditioning Again Fails to Reduce Reperfusion Injury After STEMI

CT Perfusion Imaging Captures Anatomy, Function

No Apparent Advantage for Everolimus vs. Paclitaxel Stents in Diabetic Patients

Carbon Dioxide Angiography May Be Alternative to Iodinated Contrast in High-Risk Patients

SES Fractures Raise Revascularization Risk, But Not Beyond 1 Year

ESSENCE-DIABETES Published: Xience, Cypher Equally Equipped to Treat Diabetics

Studies Support Staged PCI for STEMI Patients with Multivessel Disease

NIH Awards $84 Million Grant to NYU Langone Medical Center and Partnering Institutions for First-of-Its-Kind Comparative Effectiveness ISCHEMIA Clinical Trial

Stenting Suitable for Extracranial Vertebral Disease

OrbusNeich's GenousTM Stent Enables Early and Safe Discontinuation of Dual Antiplatelet Therapy in High-Risk Patients Requiring Nondeferrable, Non-Cardiac Surgery

St. Jude Medical Announces European Approval of First and Only Combined FFR and OCT System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content